OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Ferrari's Charles Leclerc said he had been harsh on Formula One leader Kimi Antonelli after angrily criticising ‌the Italian teenager in the heat of the Miami Grand Prix sprint race on Saturday.

RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has increased $0.13 since the market last closed. This is a 3.83 ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Adam Palasciano is a writer over three years of experience writing about personal finance, investing, student loans, and more, for outlets like GOBankingRates, FinanceBuzz, The Penny Hoarder, and Wall ...

The compound annual growth rate of a metric over time is equal to the average annual increase (or decrease) in that figure, compounded each year. It’s the “compound” here that is key. Essentially, ...